News

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
David Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
“MariTide delivered strong efficacy, including sustained weight loss without a plateau in the 52-week Phase 2 study and meaningful improvements in cardiometabolic risk factors, representing a ...